This site uses cookies to measure how you use the website so it can be updated and improved based on your needs and also uses cookies to help remember the notifications you’ve seen, like this one, so that we don’t show them to you again. If you could also tell us a little bit about yourself, this information will help us understand how we can support you better and make this site even easier for you to use and navigate.

Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer’s disease: a randomized, double-blind study


Rabey, Jose M., Dobronevsky, Evgenia, Aichenbaum, Sergio, Gonen, Ofer, Marton, Revital Gendelman, Khaigrekht, Michael


Journal Of Neural Transmission (Vienna, Austria: 1996), Volume: 120, No.: 5, Pages.: 813-819

Year of Publication



Cortical excitability can be modulated using repetitive transcranial magnetic stimulation (rTMS). Previously, we showed that rTMS combined with cognitive training (rTMS-COG) has positive results in Alzheimer’s disease (AD). The goal of this randomized double-blind, controlled study was to examine the safety and efficacy of rTMS-COG in AD. Fifteen AD patients received 1-h daily rTMS-COG or sham treatment (seven treated, eight placebo), five sessions/week for 6 weeks, followed by biweekly sessions for 3 months. The primary outcome was improvement of the cognitive score. The secondary outcome included improvement in the Clinical Global Impression of Change (CGIC) and Neuropsychiatric Inventory (NPI). There was an improvement in the average ADAS-cog score of 3.76 points after 6 weeks in the treatment group compared to 0.47 in the placebo group and 3.52 points after 4.5 months of treatment, compared to worsening of 0.38 in the placebo (P = 0.04 and P = 0.05, respectively). There was also an improvement in the average CGIC score of 3.57 (after 6 weeks) and 3.67 points (after 4.5 months), compared to 4.25 and 4.29 in the placebo group (mild worsening) (P = 0.05 and P = 0.05, respectively). NPI improved non-significantly. In summary, the NeuroAD system offers a novel, safe and effective therapy for improving cognitive function in AD.;

Bibtex Citation

@article{Rabey_2012, doi = {10.1007/s00702-012-0902-z}, url = {}, year = 2012, month = {oct}, publisher = {Springer Science $mathplus$ Business Media}, volume = {120}, number = {5}, pages = {813--819}, author = {Jose M. Rabey and Evgenia Dobronevsky and Sergio Aichenbaum and Ofer Gonen and Revital Gendelman Marton and Michael Khaigrekht}, title = {Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study}, journal = {Journal of Neural Transmission} }


aged, aged, 80 and over, alzheimer disease, analysis of variance, cognitive, cognitive therapy, double-blind method, female, humans, magnetic, magnetic resonance imaging, male, methods, neuropsychological tests, patient compliance, psychiatric status rating scales, rehabilitation, stimulation, therapy, training, transcranial, transcranial magnetic stimulation, treatment outcome, with

Countries of Study


Types of Dementia

Alzheimer’s Disease

Types of Study

Randomised Controlled Trial

Type of Outcomes

Behaviour, Cognition

Type of Interventions

Non-pharmacological Treatment

Non-Pharmaceutical Interventions

Adult safeguarding and abuse detection/prevention, Complementary therapies